Affinity Asset Advisors LLC Takes Position in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU)

Affinity Asset Advisors LLC bought a new stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 250,000 shares of the company’s stock, valued at approximately $2,538,000.

Other hedge funds have also bought and sold shares of the company. ADAR1 Capital Management LLC bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the fourth quarter worth approximately $5,065,000. Kepos Capital LP acquired a new stake in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter worth approximately $709,000. Athos Capital Ltd bought a new stake in Oaktree Acquisition Corp. III Life Sciences in the 4th quarter valued at $507,000. Finally, Rangeley Capital LLC acquired a new position in Oaktree Acquisition Corp. III Life Sciences in the 4th quarter valued at $101,000.

Oaktree Acquisition Corp. III Life Sciences Trading Down 0.9 %

OACCU stock opened at $10.26 on Tuesday. The stock’s fifty day moving average price is $10.25. Oaktree Acquisition Corp. III Life Sciences has a fifty-two week low of $9.99 and a fifty-two week high of $10.60.

About Oaktree Acquisition Corp. III Life Sciences

We are a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.